Form 4 · Filed Jun 8, 2026, 08:01 PM UTC
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo — Chief Operating Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | M | other | 15,401 | $1 | $11,551 | 715,401 |
| Jun 5, 2026 | S | sell | 15,401 | $6 | $98,566 | 700,000 |
| Jun 5, 2026 | M | other | 15,401 | — | — | 862,419 |
| Jun 4, 2026 | M | other | 19,575 | $1 | $14,681 | 719,575 |
| Jun 4, 2026 | S | sell | 19,575 | $6 | $119,995 | 700,000 |
| Jun 4, 2026 | M | other | 19,575 | — | — | 877,820 |
Source: SEC EDGAR raw filing ↗ · Accession 0001140361-26-024449